EFFECT OF FAMOTIDINE ON THE PHARMACOKINETICS OF APIXABAN, AN ORAL DIRECT FACTOR Xa INHIBITOR, IN HEALTHY SUBJECTS.

被引：0
|
作者：
Uprett, Vijay V. [1 ]
Song, Yan [1 ]
Wang, Jessie [1 ]
Farmer, Mathew [1 ]
Pursley, Janica M. [1 ]
Li, Tong [1 ]
Frost, Charles E. [1 ]
LaCreta, Frank P. [1 ]
机构：
[1] Bristol Myers Squibb Co, Princeton, NJ USA
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 2009年 / 49卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
117
引用
收藏
页码：1117 / 1117
页数：1
相关论文
共 50 条
  • [1] EFFECT OF BODY WEIGHT ON THE PHARMACOKINETICS OF APIXABAN, AN ORAL DIRECT FACTOR Xa INHIBITOR, IN HEALTHY SUBJECTS.
    Upreti, Vijay V.
    Wang, Jessie
    Barrett, Yuchen
    Boyd, Rebecca
    Bui, Anh
    Li, Tong
    LaCreta, Frank P.
    Frost, Charles E.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1060 - 1060
  • [2] Effect of famotidine on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
    Upreti, Vijay V.
    Song, Yan
    Wang, Jessie
    Byon, Wonkyung
    Boyd, Rebecca A.
    Pursley, Janice M.
    LaCreta, Frank
    Frost, Charles E.
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2013, 5 : 59 - 65
  • [3] POPULATION PHARMACOKINETICS AND PHARMACODYNAMICS OF PD 0348292, AN ORAL, DIRECT FACTOR XA INHIBITOR, IN HEALTHY SUBJECTS.
    Xuan, D.
    Boyd, R.
    DiCarlo, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 : S54 - S55
  • [4] Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa
    Vakkalagadda, Blisse
    Frost, Charles
    Byon, Wonkyung
    Boyd, Rebecca A.
    Wang, Jessie
    Zhang, Donglu
    Yu, Zhigang
    Dias, Clapton
    Shenker, Andrew
    LaCreta, Frank
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (02) : 119 - 127
  • [5] Effect of Rifampin on the Pharmacokinetics of Apixaban, an Oral Direct Inhibitor of Factor Xa
    Blisse Vakkalagadda
    Charles Frost
    Wonkyung Byon
    Rebecca A. Boyd
    Jessie Wang
    Donglu Zhang
    Zhigang Yu
    Clapton Dias
    Andrew Shenker
    Frank LaCreta
    American Journal of Cardiovascular Drugs, 2016, 16 : 119 - 127
  • [6] Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects
    Frost, Charles
    Wang, Jessie
    Nepal, Sunil
    Schuster, Alan
    Barrett, Yu Chen
    Mosqueda-Garcia, Rogelio
    Reeves, Richard A.
    LaCreta, Frank
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (02) : 476 - 487
  • [7] EFFECT OF RIFAMPIN ON THE PHARMACOKINETICS OF APIXABAN, AN ORAL DIRECT INHIBITOR OF FACTOR Xa
    Vakkalagadda, B.
    Frost, C.
    Wang, J.
    Nepal, S.
    Schuster, A.
    Zhang, D.
    Dias, C.
    Yu, Z.
    Shenker, A.
    LaCreta, F.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2009, 49 (09): : 1124 - 1124
  • [8] Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor
    Frost, Charles E.
    Byon, Wonkyung
    Song, Yan
    Wang, Jessie
    Schuster, Alan E.
    Boyd, Rebecca A.
    Zhang, Donglu
    Yu, Zhigang
    Dias, Clapton
    Shenker, Andrew
    LaCreta, Frank
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (05) : 838 - 846
  • [9] Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects
    Frost, Charles
    Nepal, Sunil
    Wang, Jessie
    Schuster, Alan
    Byon, Wonkyung
    Boyd, Rebecca A.
    Yu, Zhigang
    Shenker, Andrew
    Barrett, Yu Chen
    Mosqueda-Garcia, Rogelio
    LaCreta, Frank
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 76 (05) : 776 - 786
  • [10] Effect of food on the pharmacokinetics of darexaban, an oral direct factor Xa inhibitor, in healthy Japanese subjects
    Kadokura, Takeshi
    Taniuchi, Yuta
    Inoue, Hiroshi
    Saito, Masako
    Iwahana, Mioko
    Yamada, Shunsuke
    Urae, Akinori
    Nakamura, Mashio
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2013, 51 (03) : 200 - 206
12345